Epigenetics and cancer – A dependence relationship

[1] Feng S, De Carvalho DD. Clinical advances in targeting epigenetics for cancer therapy. FEBS J. 2022 Mar;289(5):1214–1239. doi: 10.1111/febs.15750. Epub 2021 Feb 18. PMID: 33545740. FengS De CarvalhoDD Clinical advances in targeting epigenetics for cancer therapy FEBS J. 2022 Mar 289 5 1214 1239 10.1111/febs.15750 Epub 2021 Feb 18. PMID: 33545740. 33545740 Open DOISearch in Google Scholar

[2] Liu Z, Ren Y, Weng S, Xu H, Li L, Han X. A New trend in cancer treatment: the combination of epigenetics and immunotherapy. Front Immunol. 2022 Jan 24;13:809761. doi: 10.3389/fimmu.2022.809761. PMID: 35140720; PMCID: PMC8818678. LiuZ RenY WengS XuH LiL HanX A New trend in cancer treatment: the combination of epigenetics and immunotherapy Front Immunol. 2022 Jan 24 13 809761. 10.3389/fimmu.2022.809761 PMID: 35140720; PMCID: PMC8818678. 881867835140720 Open DOISearch in Google Scholar

[3] Schübeler D. Function and information content of DNA methylation. Nature. 2015 Jan 15;517(7534):321–6. doi: 10.1038/nature14192. PMID: 25592537. SchübelerD Function and information content of DNA methylation Nature. 2015 Jan 15 517 7534 321 6 10.1038/nature14192 PMID: 25592537. 25592537 Open DOISearch in Google Scholar

[4] Magner WJ, Kazim AL, Stewart C, Romano MA, Catalano G, Grande C, et al. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol. 2000 Dec 15;165(12):7017–24. doi: 10.4049/jimmunol.165.12.7017. PMID: 11120829. MagnerWJ KazimAL StewartC RomanoMA CatalanoG GrandeC Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors J Immunol. 2000 Dec 15 165 12 7017 24 10.4049/jimmunol.165.12.7017 PMID: 11120829. 11120829 Open DOISearch in Google Scholar

[5] Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, et al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell. 2015 Aug 27;162(5):961–73. doi: 10.1016/j.cell.2015.07.056. PMID: 26317465; PMCID: PMC4843502. RouloisD Loo YauH SinghaniaR WangY DaneshA ShenSY DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts Cell. 2015 Aug 27 162 5 961 73 10.1016/j.cell.2015.07.056 PMID: 26317465; PMCID: PMC4843502. 484350226317465 Open DOISearch in Google Scholar

[6] Heiland DH, Haaker G, Delev D, Mercas B, Masalha W, Heynckes S, et al. Comprehensive analysis of PD-L1 expression in glioblastoma multiforme. Oncotarget. 2017 Jun 27;8(26):42214–42225. doi: 10.18632/oncotarget.15031. PMID: 28178682; PMCID: PMC5522061. HeilandDH HaakerG DelevD MercasB MasalhaW HeynckesS Comprehensive analysis of PD-L1 expression in glioblastoma multiforme Oncotarget. 2017 Jun 27 8 26 42214 42225 10.18632/oncotarget.15031 PMID: 28178682; PMCID: PMC5522061. 552206128178682 Open DOISearch in Google Scholar

[7] Gevensleben H, Holmes EE, Goltz D, Dietrich J, Sailer V, Ellinger J, et al. PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy. Oncotarget. 2016 Nov 29;7(48):79943–79955. doi: 10.18632/oncotarget.13161. PMID: 27835597; PMCID: PMC5346762. GevenslebenH HolmesEE GoltzD DietrichJ SailerV EllingerJ PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy Oncotarget. 2016 Nov 29 7 48 79943 79955 10.18632/oncotarget.13161 PMID: 27835597; PMCID: PMC5346762. 534676227835597 Open DOISearch in Google Scholar

[8] Karamitrousis EI, Balgkouranidou I, Xenidis N, Amarantidis K, Biziota E, Koukaki T, et al. Prognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients. Technol Cancer Res Treat. 2021 Jan–Dec;20:1533033820973279. doi: 10.1177/1533033820973279. PMID: 33928818; PMCID: PMC8113658. KaramitrousisEI BalgkouranidouI XenidisN AmarantidisK BiziotaE KoukakiT Prognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients Technol Cancer Res Treat. 2021 Jan–Dec 20 1533033820973279. 10.1177/1533033820973279 PMID: 33928818; PMCID: PMC8113658. 811365833928818 Open DOISearch in Google Scholar

[9] Karamitrousis E, Balgkouranidou I, Xenidis N, Amarantidis K, Biziota E, Koukaki T, et al. Association between SOX17, Wif-1 and RASSF1A promoter methylation status and response to chemotherapy in patients with metastatic gastric cancer. Clin Chem Lab Med. 2020 Sep 1;59(2):e73–e75. doi: 10.1515/cclm-2020-0662. PMID: 32870805. KaramitrousisE BalgkouranidouI XenidisN AmarantidisK BiziotaE KoukakiT Association between SOX17, Wif-1 and RASSF1A promoter methylation status and response to chemotherapy in patients with metastatic gastric cancer Clin Chem Lab Med. 2020 Sep 1 59 2 e73 e75 10.1515/cclm-2020-0662 PMID: 32870805. 32870805 Open DOISearch in Google Scholar

[10] Wang L, Amoozgar Z, Huang J, Saleh MH, Xing D, Orsulic S, et al. Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model. Cancer Immunol Res. 2015 Sep;3(9):1030–41. doi: 10.1158/2326-6066.CIR-15-0073. Epub 2015 Jun 8. PMID: 26056145. WangL AmoozgarZ HuangJ SalehMH XingD OrsulicS Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model Cancer Immunol Res. 2015 Sep 3 9 1030 41 10.1158/2326-6066.CIR-15-0073 Epub 2015 Jun 8. PMID: 26056145. Open DOISearch in Google Scholar

[11] Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, et al. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell. 2015 Aug 27;162(5):974–86. doi: 10.1016/j.cell.2015.07.011. Erratum in: Cell. 2016 Feb 25;164(5):1073. Buhu, Sadna [corrected to Budhu, Sadna]; Mergoub, Taha [corrected to Merghoub, Taha]. Erratum in: Cell. 2017 Apr 6;169(2):361. PMID: 26317466; PMCID: PMC4556003. ChiappinelliKB StrisselPL DesrichardA LiH HenkeC AkmanB Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses Cell. 2015 Aug 27 162 5 974 86 10.1016/j.cell.2015.07.011 Erratum in: Cell. 2016 Feb 25;164(5):1073. Buhu, Sadna [corrected to Budhu, Sadna]; Mergoub, Taha [corrected to Merghoub, Taha]. Erratum in: Cell. 2017 Apr 6;169(2):361. PMID: 26317466; PMCID: PMC4556003. 455600326317466 Open DOISearch in Google Scholar

[12] Leslie M. First EZH2 Inhibitor Approved-for Rare Sarcoma. Cancer Discov. 2020 Mar;10(3):333–334. doi: 10.1158/2159-8290.CD-NB2020-006. Epub 2020 Feb 10. PMID: 32041739. LeslieM First EZH2 Inhibitor Approved-for Rare Sarcoma Cancer Discov. 2020 Mar 10 3 333 334 10.1158/2159-8290.CD-NB2020-006 Epub 2020 Feb 10. PMID: 32041739. 32041739 Open DOISearch in Google Scholar

[13] Karamitrousis E, Balgkouranidou I, Xenidis N, Amarantidis K, Biziota E, Koukaki T, et al. Concentration of circulating tumor DNA in patients with metastatic gastric cancer and its prognostic significance. Forum Clin Oncol. 2021; 12(2): 72–76. KaramitrousisE BalgkouranidouI XenidisN AmarantidisK BiziotaE KoukakiT Concentration of circulating tumor DNA in patients with metastatic gastric cancer and its prognostic significance Forum Clin Oncol. 2021 12 2 72 76 10.2478/fco-2021-0010 Search in Google Scholar

[14] Goni M, Javaregowda PK, Chachadi V, Virupakshaiah DBM. Sialic acids: An avenue to target cancer progression, mestastasis and resistance to therapy. Forum Clin Oncol. 2021;12(2): GoniM JavaregowdaPK ChachadiV VirupakshaiahDBM Sialic acids: An avenue to target cancer progression, mestastasis and resistance to therapy Forum Clin Oncol. 2021 12 2 10.2478/fco-2021-0006 Search in Google Scholar

[15] Sharma H, Kumar G, Kaur CD. Development of bioflavonoid containing chemotherapeutic delivery systems for UV damaged skin and kangri cancer. Forum Clin Oncol. 2021;12 (2): 86–98. SharmaH KumarG KaurCD Development of bioflavonoid containing chemotherapeutic delivery systems for UV damaged skin and kangri cancer Forum Clin Oncol. 2021 12 2 86 98 10.2478/fco-2021-0012 Search in Google Scholar